CarriganJ., JordanC. M.: Heparin therapy in septhicemia with disseminated intravascular coagulation. Effect on mortality and on correction of hemostatic defects. New England J. Med., 283; 778 (1970).
7.
ClarksonA. R., SageR.E., LawrenseL. B.: Consumption coagulopathy and acute renal failure due to Gram-negative septicemia after obortiom. Ann. Int. Med., 70; 1191 (1969).
8.
CashJ. D.: Comunicazione tenuta al Corso di aggiornamento su alterazioni congenite ed acquisite della coagulazione. Milano1973.
9.
CoccheriS.: La trombogenesi nei vasi umani. Significato dei fattori fibrinoformativi e fibrinolitici della parete vascolare, Communicaz. XVII Congr. Naz. Soc. it. Emat., Genova 1960.
DeykinD.: The role of the liver in serum-induced hypercoagulability. J. Clin. Invest., 45; 256 (1966).
12.
DeykinD., CochiasF., De CampG.: Hepatic removal of activated factor X by the perfused rabbit liver, Ann. J. Phisiol., 214; 414 (1968).
13.
DeykinD.: The clinical challenge of disseminated intravascolar coagulation. New England J. Med., 17; 636 (1970).
14.
FareH., BreandPh., BauvierC., ChatelonatF.: Étude du retentissement rénale des coagulopathies intravasculaires. J. d'Urol., 78; 311 (1972).
15.
FedderG., PrakkeE. M., VreekenJ.: citati da Cash.
16.
FletcherA. P., AlkjaersigN., FisherS.: The proteolysis of fibrinogen by plasmin, the identification of trombin-clottable derivatives which polymerize abnormally. J. Lab. Clin. Med., 68; 780 (1966).
17.
HardwayR. M., HusniE. A.: Endotoxin shock. A manifestation of intravascolar coagulation. Ann. Sur., 154; 791 (1961).
18.
HardwayR. M.: Disseminated intravascolar coagulation in experimental and clinical shock. Amer. J. Cardiol., 20; 161 (1967).
19.
HawigerJ., NiewiarowskiS., FurewichV.: Measurament of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J. Lab. Clin. Med.75; 93 (1970).
JensenH.: Dynamic concept of fibrin formation and lysis in relation to hemorrhage and trombosis. Exp. Med. Sur., 14; 189 (1956).
22.
JurgensR., TrautweinH.: Ueber fibrinopenia beim Erwachsenen nebst Bemerkungen über die Herkumft des Fibrinogens. Deutsch. Arch. klin. Med., 169; 28 (1930).
23.
KampD. M., DonaldsonM. H.: Am. J. Dis. Childhood, 119; 114 (1970).
24.
KleinknechtD., KamperA., CassonA., GremfeldJ. P.: Coagulation intravascolaire disseminée chez 49 malades atteints d'insuffisance rénale aiguë. J. d'Urol., 78; 330 (1972).
MaorkerjeeB. K., BilefskyR., KendallA. G., DossetarJ. B.: Generalized Shwartzman reaction due to Gram-negative septicemia after abortion; recovery after bilateral cortical necrosis. Canad. Med. Ass. J., 69; 578 (1968).
29.
MarderV. J., ShulmanN. R.: High molecular weight derivatives of human fibrinogen produced by plasmin. 2o: mechanism of their anticoagulant artivity. J. Biol. Chem., 244; 2120 (1969).
30.
MasonJ. W., KlefborgU., DonanP., ColmanR. W.: Ann. Iintern. Med., 73; 345 (1970).
31.
MasonJ. W., ColmanR. W.: Tromb. diath. hacmor., 26; 325 (1971).
32.
McGrathJ. M., StewartG. J.: J. Exper. Med., 129; 833 (1969).
33.
MiglioriM., De MolfettaV.: Possibilità di trattamento della trombosi retinica con attivatori del sistema fibrinolitico (estratto di parete arteriosa). Minerva oftalmolog., 7; 81 (1965).
34.
NaeyeR. L.: Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood., 19; 694 (1962).
PenickG. D., RobertsH. R., NebsterW. P., BrinkhausK. M.: Hemorrhagic states secondary to intravascular clotting. An experimental study of their evolution and prevention. Arch. Pathol., 66; 708 (1958).
38.
PeregoM. A., IsidoriA., AlloriL.: Meccanismo fibrinolitico della parete arteriosa. Policlinico, 69; 1353 (1962).
39.
PickensR. L., LattimerJ. K.: Disseminated intravascular coagulation. Diagnosis and treatment of a hemorrhagic diathesis after prostatectomy. J. Urol., 108; 951 (1972).
40.
PolliackA.: Am. J. Clin. Pathol., 56; 115 (1971).
41.
QuickA. J., HusseyC. V., HarrisJ., PetersK.: Occult intravascular clotting by means of intravenous injection of trombin. Am. J. Physiol., 197; 791 (1959).
42.
Rodriquez-ErdmannF.: Bleeding due to increased intravascular blood coagulation. Hemorrhagic sindromes caused by consumption of blood-clotting factors. New Engl. J. Med., 273; 1370 (1965).
43.
RebenbergM. L., BakerL. R., McBridgeJ. A., SevittL. H., BrainM. C.: Intravascular coagulation in a case of Clostridium perfringens septcemia. Treatment by exchange transfusions and heparin. Brit. Med. J., 4; 271 (1967).
44.
SealeR. A., JampolisR. W., BorgensJ. A.: Symposium on surgical aspects of cancer problem; clotting defect in the presente of metastatic carcinoma of prostate, case report. Surg. Clin. N. Amer., 31; 111 (1951).
45.
SeergesW. H., LandaburuR. H., JohnsonJ. F.: Trombin-E as a fibrinolitic enzime. Science, 131; 726 (1960).
46.
SherryS., FletcherA. P., AlkjaersigN.: Frinolysis and fibrinolitic activity in man. Physiol. Rev., 39; 343 (1959).
TagnonD. J., WhitmoreW. F., ShulmanN. R.: Fibrinolysis in metastatic cancer of the prostate. Cancer, 5; 9 (1952).
49.
TognonH. J., ShulmanN. R., WhitmoreW. F., LeoneL. A.: Prostatic fibrinolysis; study of a case illustrating role in haemorrhagic diathesis of cancer of the prostate. Am. J. Med., 15; 875 (1953).
50.
VerstaeteM., AmeryA., VermylenC.: Diagnostic hints for intravascular coagulation and its treatment with heparin. Acta Clin. Bel., 18; 480 (1963).
51.
VerstraeteM., VermylenC.: Acute and chronic defibrination in obstetrical pratice. Thromb. diath. haemor., 20; 370 (1968).
52.
von FranckenI., JohnsonL., OlssonP., ZettergvistE.: Eparin treatment of bleending. Clinical observation. Lancet, 1, 70 (1963).